PaulKwoMD
Gastroenterology • Stanford, CAHepatology & Liver Transplantation
Professor of Medicine, Stanford University
Dr. Kwo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1992 - 1995
University of MarylandResidency, Internal Medicine, 1988 - 1991
Wayne State University School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 2016 - 2025
IN State Medical License 1995 - 2017
MN State Medical License 1992 - 1995
MD State Medical License 1990 - 1992
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Indianapolis Monthly Castle Connolly, 2007, 2009-2011, 2013
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Study of Telaprevir in Subjects With Hepatic Impairment Start of enrollment: 2007 Sep 01
- Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation Start of enrollment: 2013 Jun 01
- Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) Start of enrollment: 2014 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.Homie A Razavi, Imam Waked, Huma Qureshi, Loreta A Kondili, Ann-Sofi Duberg
Journal of Hepatology. 2025-02-04 - Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0.Di Wu, Jia-Horng Kao, Teerha Piratvisuth, Xiaojing Wang, Patrick T F Kennedy
Clinical and Molecular Hepatology. 2025-02-01 - Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease.W Ray Kim, Ajitha Mannalithara, Vivek Charu, Nakia Chung, Allison Kwong
The American Journal of Gastroenterology. 2025-01-03
Journal Articles
- Diagnosis and Management of Primary Biliary CholangitisZobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature
- Response to Perrella Et AlPaul Y Kwo, Mitchell L Shiffman, Nature
Authored Content
- Reflections on Key Presentations at ACG 2021November 2021
Press Mentions
In MASLD Patients, Bariatric Surgery Shows Better 5-Year Survival Than Weight-Loss MedsFebruary 17th, 2025
DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a TrialMay 7th, 2019
DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial ResultsMay 3rd, 2019- Join now to see all
Grant Support
- Alcohol Utilization Rates Determined By Alcohol Clamping--Effect Of Age, GenderNational Center For Research Resources1997–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
